KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Non-cash Items (2010 - 2014)

Edwards Lifesciences' quarterly Non-cash Items came in at $381.3 million in Q4 2014, up 7232.69% year-on-year from $5.2 million in Q4 2013, and up 7232.69% quarter-over-quarter from $5.2 million in Q4 2013.

Edwards Lifesciences has reported Non-cash Items for 5 years, with the latest figure at $381.3 million in Q4 2014.

  • For the quarter ending Q4 2014, Non-cash Items rose 7232.69% year-over-year to $381.3 million; the trailing twelve-month figure through Dec 2014 stood at $381.3 million (up 7232.69% YoY), and the FY2014 full-year result was $381.3 million, up 7232.69% from the prior year.
  • Non-cash Items for Q4 2014 stood at $381.3 million, up from $5.2 million in the prior quarter.
  • The five-year high for Non-cash Items was $598.5 million in Q4 2010, with the low at $5.2 million in Q4 2013.
  • Average Non-cash Items over 5 years is $330.3 million, with a median of $362.4 million recorded in 2011.
  • Year-over-year, Non-cash Items plunged 98.29% in 2013 and jumped 7232.69% in 2014.
  • Tracing EW's Non-cash Items over 5 years: stood at $598.5 million in 2010, then tumbled by 39.45% to $362.4 million in 2011, then retreated by 16.03% to $304.3 million in 2012, then sank by 98.29% to $5.2 million in 2013, then jumped by 7232.69% to $381.3 million in 2014.
  • The last three Non-cash Items figures came in at $381.3 million (Q4 2014), $5.2 million (Q4 2013), and $304.3 million (Q4 2012), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2014 381.30 Mn
Dec 31, 2014 381.30 Mn
Dec 31, 2013 5.20 Mn
Dec 31, 2013 5.20 Mn
Dec 31, 2012 304.30 Mn
Dec 31, 2012 304.30 Mn
Dec 31, 2011 362.40 Mn
Dec 31, 2011 362.40 Mn
Dec 31, 2010 598.50 Mn
Dec 31, 2010 598.50 Mn